← Back to Clinical Trials
Recruiting NCT07298629

NCT07298629 Product Information Analysis and Clinical Verification - Clinical Verification of New Smart Health Medical Shoes/Insoles

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07298629
Status Recruiting
Phase
Sponsor National Taiwan University Hospital
Condition Pronated Foot
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-07-01
Primary Completion 2026-12-31

Trial Parameters

Condition Pronated Foot
Sponsor National Taiwan University Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 20 Years
Max Age 65 Years
Start Date 2024-07-01
Completion 2026-12-31
Interventions
3d printed insole

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

As part of foot orthotics, insoles play a crucial role in adjusting biomechanical malalignments of the foot and regulating foot pressure. They are commonly used as a clinical tool for correcting foot problems. Currently, most customized insole manufacturing processes mainly depend on traditional or subtractive methods, highly dependent on the manual technology of the manufacturer, and the production capacity is constrained by working hours and cannot be manufactured in large quantities. Consequently, people often need to wait for one to two months with poor timeliness. The 3D printing insole fabrication process offers significant advantages in customization with high design flexibility and freedom. Utilizing microstructural zoning designs can better combine different regional characteristic requirements, thus closely addressing individual requirements. The purpose of this project is to validate the medical process after the initial development of the novel intelligent health medical insole and subsequently introduce the new intelligent health medical insole into clinical applications within medical institutions. The project plans to recruit 30 participants with foot pain. Participants will be required to provide basic information and evaluated their foot condition. the Tiger Scan 3D full-foot scanning equipment will be used to capture the participants' 3D foot models. Insoles will be customized based on the assessment results, incorporating features such as heel cups, arch supports, and medial wedges. Relevant parameters will be uploaded to a RESTful API correction information platform. Then, the clinical recommendations for adjustment parameters will be output to a 3D printer, producing customized insoles with selective laser sintering (SLS) technology. The outcome assessments encompass short-term and long-term evaluations. Short-term assessments include kinematics and dynamic analysis, foot pressure distribution, physical performance, and foot morphology. Long-term assessments include pain levels, activities of daily living, and changes in quality of life.

Eligibility Criteria

Inclusion Criteria: 1. Obvious medial arch collapse 2. Foot posture index (FPI) score of 6 or higher Exclusion Criteria: 1. experience wearing custom-made insoles within the past 6 months; 2. experience of lower limb injury, surgery, acute infection, or other complications within the past 6 months 3. a body mass index (BMI) greater than 35; 4. rheumatoid arthritis; 5. cognitive impairment preventing obedience; 6. systemic diseases affecting the nervous, muscular, skeletal, or circulatory systems

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology